MASSMUTUAL TRUST CO FSB/ADV - ENCOMPASS HEALTH CORP ownership

ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 394 filers reported holding ENCOMPASS HEALTH CORP in Q2 2019. The put-call ratio across all filers is 1.48 and the average weighting 0.1%.

Quarter-by-quarter ownership
MASSMUTUAL TRUST CO FSB/ADV ownership history of ENCOMPASS HEALTH CORP
ValueSharesWeighting
Q2 2024$14,842
+39.3%
173
+34.1%
0.00%
Q1 2024$10,653
+23.8%
1290.0%0.00%
Q4 2023$8,607
+2.5%
129
+3.2%
0.00%
Q3 2023$8,395
-7.5%
125
-6.7%
0.00%
Q2 2023$9,073
+37.5%
134
+9.8%
0.00%
Q1 2023$6,600
+109900.0%
122
+29.8%
0.00%
Q4 2022$6
-99.8%
940.0%0.00%
Q3 2022$4,000
+100.0%
94
+213.3%
0.00%
Q2 2022$2,000
-50.0%
30
-43.4%
0.00%
Q1 2022$4,000
-42.9%
53
-50.5%
0.00%
Q4 2021$7,000
+75.0%
107
+81.4%
0.00%
Q3 2021$4,000
-20.0%
590.0%0.00%
Q2 2021$5,000
-98.8%
59
-98.8%
0.00%
-100.0%
Q1 2021$413,000
-22.8%
5,040
-22.1%
0.02%
-29.6%
Q4 2020$535,000
+9.6%
6,472
-13.9%
0.03%
-6.9%
Q3 2020$488,000
+26.4%
7,516
+20.5%
0.03%
+16.0%
Q2 2020$386,000
-25.9%
6,237
-23.3%
0.02%
-40.5%
Q1 2020$521,000
-17.3%
8,132
-10.5%
0.04%
+7.7%
Q4 2019$630,000
+2.6%
9,091
-6.3%
0.04%
-4.9%
Q3 2019$614,000
-3.2%
9,698
-3.0%
0.04%
-6.8%
Q2 2019$634,000
-95.2%
9,999
+4363.8%
0.04%
+4300.0%
Q1 2019$13,082,000
-32.0%
224
-28.2%
0.00%
-50.0%
Q4 2018$19,250,000
-20.8%
3120.0%0.00%0.0%
Q3 2018$24,320,000
+13.3%
312
-1.6%
0.00%0.0%
Q2 2018$21,467,000
+18.5%
3170.0%0.00%
+100.0%
Q1 2018$18,123,0003170.00%
Other shareholders
ENCOMPASS HEALTH CORP shareholders Q2 2019
NameSharesValueWeighting ↓
Iron Triangle Partners LP 697,659$45,334,00010.13%
JANA PARTNERS LLC 1,741,513$113,164,00010.12%
Endurant Capital Management LP 276,105$17,941,0005.31%
REINHART PARTNERS, LLC. 726,140$47,184,0003.55%
Prosight Management, LP 107,921$7,013,0003.34%
Advantage Alpha Capital Partners LP 160,234$10,412,0002.41%
RK Capital 115,800$7,525,0002.13%
Copeland Capital Management, LLC 700,015$45,487,0002.02%
Sivik Global Healthcare LLC 65,000$4,224,0001.82%
Walthausen & Co., LLC 120,016$7,799,0001.62%
View complete list of ENCOMPASS HEALTH CORP shareholders